The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
About this item
Full title
Author / Creator
Publisher
Basel: MDPI AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel: MDPI AG
Subjects
More information
Scope and Contents
Contents
Resistant hypertension (R-HTN) implies a higher mortality and morbidity compared to non-R-HTN due to increased cardiovascular risk and associated adverse outcomes—greater risk of developing chronic kidney disease, heart failure, stroke and myocardial infarction. R-HTN is considered when failing to lower blood pressure below 140/90 mmHg despite adeq...
Alternative Titles
Full title
The Road to Better Management in Resistant Hypertension—Diagnostic and Therapeutic Insights
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cfca60d56bf84325ac2af9ddc7028dd9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cfca60d56bf84325ac2af9ddc7028dd9
Other Identifiers
ISSN
1999-4923
E-ISSN
1999-4923
DOI
10.3390/pharmaceutics13050714
